Morning Market Gainers - Exelixis (NASDAQ:EXEL), Cellectis (NASDAQ:CLLS)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Exelixis, Inc. (NASDAQ: EXEL) shares jumped 47.57 percent to $5.77 after the company reported positive top-line results from METEOR, Phase 3 pivotal trial of Cabozantinib vs. Everolimus in patients with metastatic renal cell carcinoma.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Vivint Solar Inc (NYSE: VSLR) shares climbed 43.89 percent to $15.67 after the company agreed to be acquired by Sunedison Inc (NASDAQ: SUNE) for $2.2 billion.Lennox International Inc. (NYSE: LII) shares surged 9.50 percent to $117.81 on better-than-expected Q2 earnings.

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.

Hasbro, Inc. (NASDAQ: HAS) gained 5.66 percent to $82.68 after the company reported upbeat Q2 results.

Horizon Pharma PLC (NASDAQ: HZNP) rose 5.23 percent to $39.02 after the company issued a strong Q2 sales forecast. Halliburton Company (NYSE: HAL) shares surged 3.19 percent to $41.28 after the company reported stronger-than-expected results for its second quarter. Cellectis SA (ADR) (NASDAQ: CLLS) shares gained 3.07 percent to $41.00. Bank of America initiated coverage on Cellectis with a Buy rating and a $50.00 price target. Morgan Stanley (NYSE: MS) shares rose 1.65 percent to $40.90 after the company reported upbeat earnings for the second quarter.